• Visen Pharmaceuticals independent non-executive director Dr. Yao Zhengbin (Bing) resigned effective Aug. 27, 2026, citing other business commitments.
• His exit triggered committee reshuffles, with independent non-executive director Zhang Qing joining the nomination committee.
• Non-executive director Michael J. Chang was appointed to the audit committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Visen Pharmaceuticals published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260827-12303417), on August 27, 2026, and is solely responsible for the information contained therein.